Ground Glasslike Hepatocytes Produced by Glycogen-Membrane Complexes (“Glycogen Bodies”)

References

• Ghadially FN. Ultrastructural Pathology of the Cell and Matrix. 3rd Ed. Butterworth, London 1988; 520
   Google Scholar
• Steiner JW, Miyai K, Phillips MJ. Electron microscopy of membrane-particle arrays in liver cells of ethionine-intoxicated rats. Am J Pathol 1964; 44: 169–213
   PubMed Web of Science ®Google Scholar
• Altmann H-W. Drug-induced liver reactions: a morphological approach. Drug-Induced Pathology. Current Topics in Pathology, E Grundmann. Springer-Verlag, New York 1980; 69–142, 69
   Google Scholar
• Ishak KG. New developments in diagnostic liver pathology. Pathogenesis of Liver Diseases, E Farber, MJ Phillips, N Kaufman. Williams and Wilkins, Baltimore 1987; 223–373, 28
   Google Scholar
• Remmer H, Merker H-J. Enzyminduktion und Vermehrung von endoplasmatischen Reticulum in der Leberzelle während der Behandlung mit Phenobarbital (Luminal) [Enzyme induction and increase of endoplasmic reticulum in liver cells during phenobarbital therapy]. Klin Wschr 1963; 41: 276–283
   PubMedGoogle Scholar
• Klinge O, Bannasch P. Zur Vermehrung des glatten endoplasmatischen Retikulum in Hepatocyten menschlicher Leberpuntate [Increase of smooth endoplasmic reticulum in hepatocytes of human liver biopsies]. Verh Dtsch Gesellsch Pathol 1968; 52: 568–573
   PubMedGoogle Scholar
• Winckler K, Junge U, Creutzfeldt W. Groundglass hepatocytes in unselected liver biopsies. Ultrastructure and relationship to hepatitis B surface antigen. Scand J Gastroenterol 1976; 11: 167–170
   PubMed Web of Science ®Google Scholar
• Jézéquel A-M, Orlandi F. Fine morphology of the human liver as a tool in clinical pharmacology. Liver and Drugs, F Orlandi, A-M Jézéquel. Academic Press, London 1972; 145–192
   Google Scholar
• Phillips MJ, Poucell S, Patterson J, Valencia P. The Liver. An Atlas and Text of Ultrastructural Pathology. Raven Press, New York 1987
   Google Scholar
• Hadziyannis S, Gerber MA, Vissoulis C, Popper H. Cytoplasmic hepatitis B antigen in “groundglass” hepatocytes of carriers. Arch Pathol 1973; 96: 327–330
   PubMedGoogle Scholar
• Shikata T, Uzawa T, Yoshiwara N, Akatsuka T, Yamazaki S. Staining methods of Australia antigen in paraffin section. Detection of cytoplasmic inclusion bodies. Jap J Exp Med 1974; 44: 25–36
   PubMedGoogle Scholar
• Huang S-N. Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections. Lab Invest 1975; 33: 88–95
   PubMed Web of Science ®Google Scholar
• Stein O, Fainaru M, Stein Y. Visualization of virus-like particles in endoplasmic reticulum of hepatocytes of Australia antigen carriers. Lab Invest 1972; 26: 262–269
   PubMed Web of Science ®Google Scholar
• Carlson J. Endoplasmic reticulum storage disease. Histopathology 1990; 16: 309–312
   PubMedGoogle Scholar
• Berg NO, Eriksson S. Liver disease in adults with alpha 1-antitrypsin deficiency. New Engl J Med 1972; 287: 1264–1267
   PubMed Web of Science ®Google Scholar
• Lieberman J, Mittman C, Gordon HW. Alpha1 antitrypsin in the livers of patients with emphysema. Science 1972; 175: 63–65
   PubMed Web of Science ®Google Scholar
• Campra JL, Craig JR, Peters RL, Reynolds TB. Cirrhosis associated with partial deficiency of alpha-1 antitrypsin in an adult. Ann Intern Med 1973; 78: 233–238
   PubMed Web of Science ®Google Scholar
• Palmer PE, Wolfe HJ, Gherardi GJ. Hepatic changes in adult α1-antitrypsin deficiency. Gastroenterology 1973; 65: 284–293
   PubMedGoogle Scholar
• Stromeyer FW, Ishak KG, Gerber MA, Mathew T. Ground-glass cells in hepatocellular carcinoma. Am J Clin Pathol 1980; 74: 254–258
   PubMed Web of Science ®Google Scholar
• Callea F, De Vos R, Togni R, Tardanico R, Vanstapel MJ, Desmet VJ. Fibrinogen inclusions in liver cells: a new type of ground-glass hepatocyte. Immune light and electron microscopic characterization. Histopathology 1986; 10: 65–73
   PubMedGoogle Scholar
• Ng I OL, Ng M, Lai E CS, Wu PC. Endoplasmic storage disease of liver: characterization of intracytoplasmic hyaline inclusions. Histopathology 1989; 15: 473–481
   PubMedGoogle Scholar
• Porte A, Batzenschlager A, Stoeckel ME, Bockel R, Girard M, Doffoël M. Storage of proteins in the rough endoplasmic reticulum of human hepatocytes in a patient with normal blood proteins on oral contraceptives. Virchows Arch A Path Anat and Histol 1977; 375: 241–248
   PubMedGoogle Scholar
• Nakanuma Y, Kono N, Ohta G, et al. Pale eosinophilic inclusions simulating ground-glass appearance of cells of hepatocellular carcinoma. Acta Path Jap 1981; 32: 71–81
   Google Scholar
• Mierau GW, Orsini EN. Case 1. Ultrastruct Pathol 1983; 5: 273–279
   PubMed Web of Science ®Google Scholar
• Ichida T. Ultrastructural study of intracytoplasmic deposits in human hepatocellular carcinoma. Gastroenterol Jap 1983; 18: 560–576
   PubMedGoogle Scholar
• Ng I OL, Sturgess RP, Williams R, Portmann B. Ground-glass hepatocytes with Lafora bodylike inclusions—histochemical, immunohistochemical and electronmicroscopic characterization. Histopathology 1990; 17: 109–115
   PubMedGoogle Scholar
• Reed GB, Dixon J FP, Neustein HB, Donnell GN, Landing BH. Type IV glycogenosis. Patient with absence of a branching enzyme α-1, 4-glucan: α-1, 4-glucan 6-glycosyl transferase. Lab invest 1968; 19: 546–557
   PubMedGoogle Scholar
• Schochet SS, McCormick WF, Zellweger H. Type IV glycogenosis (amylopectinosis). Light and electron microscopic observations. Arch Pathol 1970; 90: 354–363
   PubMedGoogle Scholar
• Bannayan GA, Dean WJ, Howell RR. Type IV glycogen-storage disease. Light-microscopic, electron-microscopic and enzymatic study. Am J Clin Pathol 1976; 66: 702–709
   PubMedGoogle Scholar
• Harriman D GF, Millar J HD. Progressive familial myoclonic epilepsy in three families: its clinical features and pathological basis. Brain 1955; 78: 328–349
   Google Scholar
• Schwarz GA, Yanoff M. Lafora's disease. Distinct clinico-pathologic form of Unverricht's syndrome. Arch Neurol 1965; 12: 172–188
   PubMedGoogle Scholar
• Nishimura RN, Ishak KG, Reddick R, Porter R, James S, Barranger JA. Lafora disease: diagnosis by liver biopsy. Ann Neurol 1980; 8: 409–415
   PubMedGoogle Scholar
• Vázquez JJ, Cervera S. Cyanamide-induced liver injury in alcoholics. Lancet 1980; 1: 361–362
   PubMedGoogle Scholar
• Bruguera M, Lamar C, Bernet M, Rodés J. Hepatic disease associated with ground-glass inclusions in hepatocytes after cyanamide therapy. Arch Pathol Lab Med 1986; 110: 906–910
   PubMed Web of Science ®Google Scholar
• Vázquez JJ, Pardo-Mindan J. Liver cell injury (bodies similar to Lafora's) in alcoholics treated with disulfiram (Antabuse). Histopathology 1979; 3: 377–384
   PubMed Web of Science ®Google Scholar
• Carasso N. Rôle de I'ergastoplasme dans l'éla-boration du glycogène au cours de la formation du paraboloide des cellules visuelles [Role of the ergastoplasm in the synthesis of glycogen during the course of formation of the “paraboloid”). Compt Rend Acad Sci Paris Ser D 1960; 250: 600–602
   PubMedGoogle Scholar
• Yamada E. The fine structure of the paraboloid in the turtle retina as revealed at electron microscopy. Anat Rec. 1960; 137: 172, Abstract
   Google Scholar
• Cohen Al. The fine structure of the visual receptors of the pigeon. Exp Eye Res 1963; 2: 88–97
   PubMedGoogle Scholar
• Biava C, Mukhlova-Montiel M. Electron microscopic observations on Councilman-like acidophilic bodies and other forms of acidophilic changes in human liver cells. Am J Pathol 1965; 46: 775–802
   PubMed Web of Science ®Google Scholar
• Tanikawa T. Ultrastructural Aspects of the Liver and Its Disorders. Springer-Verlag and Tokyo, New York 1968, Igaku Shoin
   Google Scholar
• Wills EJ. Acute infective hepatitis. Fine structural and cytochemical alterations in human liver. Arch Pathol 1968; 86: 184–207
   PubMedGoogle Scholar
• Porta E, Bergman BJ, Stein AA. Acute alcoholic hepatitis. Am J Pathol 1965; 46: 657–689
   PubMedGoogle Scholar
• Schubert WK., Partin JC, Partin JS. Encephalopathy and fatty liver (Reye's syndrome). Progress in Liver Diseases, H Popper, F Schaffner. Grune and Stratton, New York 1972; 489–510, 4
   Google Scholar
• Wills EJ, Walton B. A morphologic study of unexplained hepatitis following halothane anesthesia. Am J Pathol 1978; 91: 11–32
   PubMedGoogle Scholar
• Chedid A, Spellberg MA, De Beer RA. Ultrastructural aspects of primary biliary cirrhosis and other types of cholestatic liver disease. Gastroenterology 1974; 67: 858–869
   PubMedGoogle Scholar
• Ghadially FN, Parry EW. Ultrastructure of a human hepatocellular carcinoma and surrounding non-neoplastic liver. Cancer 1966; 19: 1989–2004
   PubMedGoogle Scholar
• Hoyes AD. The human foetal yolk sac. An ultrastructural study of four specimens. Z Zellforsch Mikr Anat 1969; 99: 469–490
   PubMedGoogle Scholar
• Sforza V, del Vecchio MT, de Santi MM, Danero S, Tondi F. An uncommon ovarian tumor. Ultrastruct Pathol 1984; 7: 59–65, The quarterly case
   PubMed Web of Science ®Google Scholar
• Mair W GP, Tomé F MS. Changes in muscle fibres. Atlas of the Ultrastructure of Diseased Human Muscle. Churchill Livingstone, London 1972; 46–137
   Google Scholar
• Thiedemann K-U, Ferrans VJ. Ultrastructure of sarcoplasmic reticulum in atrial myocardium of patients with mitral valvular disease. Am J Pathol 1976; 83: 1–38
   PubMed Web of Science ®Google Scholar
• Heuson-Stiennon J-A, Drochmans P. Morphogenése de la cellule musculaire striée, etudiée au microscope électronique. II Localisation et structure du glycogène [Morphogenesis of the striated muscle cell, studied in the electron microscope. II Localisation and morphology of glycogen]. J Microscopie 1967; 6: 639–656
   Google Scholar
• Garant PR. Glycogen-membrane complexes within mouse striated muscle cells. J Cell Biol 1968; 36: 648–652
   PubMedGoogle Scholar
• Davidowitz J, Philips G, Breinin GM. Ivlembrane-glycogen complexes in rabbit extraocular muscle. J Ultrastruct Res 1983; 82: 64–75
   PubMedGoogle Scholar
• Le Beux YJ. An unusual ultrastructural association of smooth membranes and glycogen particles: the glycogen body. Z Zellforsch Mikroscop Anat 1969; 101: 433–447
   Google Scholar
• Malassiné A. Localisation ultrastructurale et cytochimique de glycogène dans le placenta de chatte: présence de corps glycogéniques [Ultrastructural and cytochemical localisation of glycogen in the cat placenta: presence of “glycogen bodies”). Compt Rend Acad Sci Paris Ser D 1974; 278: 629–632
   PubMedGoogle Scholar
• Pannese E. Unusual membrane-particle complexes within nerve cells of the spinal ganglia. J Ultrastruct Res 1969; 29: 334–342
   PubMedGoogle Scholar
• Hirano A. Changes in the neuronal endoplasmic reticulum in the peripheral nervous system in mutant hamsters with hind leg paralysis and normal controls. J Neuropath Exp Neurol 1978; 37: 75–84
   PubMedGoogle Scholar
• Seïte R. Recherches sur I'ultrastructure, la nature et la signification des inclusions microfibrillaires paracrystallines des neurones sympathiques [Investigations on the ultrastructure, nature and significance of microfibrillar paracrystalline inclusions in sympathetic neuronsl. Z Zellforsch 1969; 101: 621–646
   PubMedGoogle Scholar
• Corvaja N, Magherini PC, Pompeiano O. Ultrastructure of glycogen-membrane complexes in sensory nerve fibres of cat muscle spindles. Z Zellforsch 1971; 121: 199–217
   PubMedGoogle Scholar
• Petit A. Ultrastructure de la rétine de I'oeil pariétal d'un Lacertilien, Anguis fragilis [Ultrastructure of the retina in the parietal eye of a Lacertilian, Anguis fragilis]. Z Zellforsch Microscop Anat 1968; 92: 70–93
   PubMedGoogle Scholar
• McCaughan GW, Tiller D, Wills EJ, Gallagher ND. Prognostic significance of jaundice after renal transplantation. Aust NZ J Med 1980; 10: 107–108, Abstract
   PubMedGoogle Scholar
• Briggs WA, Lazarus JM, Birtch AG, Hampers CL, Hager EB, Merrill JP. Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences. Arch Intern Med 1973; 132: 21–28
   PubMedGoogle Scholar
• Ireland P, Rashid A, von Lichtenberg F, Cavallo T, Merrill JP. Liver disease in kidney transplant patients receiving azathioprine. Arch Intern Med 1973; 132: 29–37
   PubMedGoogle Scholar
• Millard PR, Herbertson BM, Evans DB, Calne RY. Azathioprine hepatotoxicity in renal transplantation. Transplantation 1973; 16: 527–530
   Google Scholar
• Berne TV, Chatterjee SN, Craig JR, Redeker AG, Payne JE. Hepatic dysfunction in recipients of renal allografts. Surg Gynecol Obstet 1975; 141: 171–175
   PubMedGoogle Scholar
• Ware AJ, Luby JP, Eigenbrodt EH, Long DL, Hull AR. Spectrum of liver disease in renal transplant recipients. Gastroenterology 1975; 68: 755–764
   PubMed Web of Science ®Google Scholar
• Zimmerman HJ. Hepatotoxicity. The Adverse Effects of Drugs and Other Chemicals on the Liver. Appleton-Century-Crofts, New York 1978
   Google Scholar
• Dienstag JL. Non-A, non-B hepatitis. Advances in Internal Medicine, GH Stollerman. Year Book Publishers lnc, Chicago 1980; 187–233, 26
   Google Scholar
• Dienes HP, Popper H, Arnold W, Lobeck H. Histologic observations in human hepatitis non-A, non-B. Hepatology 1982; 2: 562–571
   PubMed Web of Science ®Google Scholar
• Huang S-N, Fisher MM. Pathology of viral hepatitis. Pathogenesis of Liver Diseases, E Farber, MJ Phillips, N Kaufman. Williams and Wilkins, Baltimore 1987; 153–198, 28
   Google Scholar
• Underwood J CE. Hepatitis C virus and transfusion transmitted liver disease: Review. J Clin Pathol 1990; 43: 445–447
   PubMedGoogle Scholar
• De Vos R, Vanstapel MJ, Desmyter J, et al. Are nuclear particles specific for non-A, non-B hepatitis. Hepatology 1983; 3: 532–544
   PubMed Web of Science ®Google Scholar
• Dargie HJ, Dollery CT. Adverse reactions to diuretic drugs. Meyler's Side Effects of Drugs, M NG Dukes. Excerpta Medica, Oxford 1975; 483–501, 8
   Google Scholar
• Strieker B HCH, Spoelstra P. Drug-induced hepatic injury. DrugInduced Disorders, M NG Dukes. Elsevier, New York 1985; 211–212; 233, 1
   Google Scholar
• Corley CC, Lessner HE, Larsen WE. Azathioprine therapy of “autoimmune” diseases. Am J Med 1966; 41: 404–412
   PubMed Web of Science ®Google Scholar
• Sparberg M, Simon N, del Greco F. Intrahepatic cholestasis due to azathioprine. Gastroenterology 1969; 57: 439–441
   PubMed Web of Science ®Google Scholar
• Malekzadeh MH, Grushkin CM, Wright HT, Fine RN. Hepatic dysfunction after renal transplantation in children. J Pediatr 1972; 81: 279–285
   PubMedGoogle Scholar
• Zarday Z, Veith FJ, Gliedman ML, Soberman R. Irreversible liver damage after azathioprine. JAMA 1972; 222: 690–691
   PubMedGoogle Scholar
• Freise J, May B, Schmidt E. Cholestatischer ikterus nach azathioprin [Cholestatic jaundice after azathioprine treatment]. Dtsch Med Wschr 1976; 101: 1223–1226
   PubMedGoogle Scholar
• Menard DB, Gisselbrecht C, Marty M, Reyes F, Dhameaux D. Antineoplastic agents and the liver. Gastroenterology 1980; 78: 142–164
   PubMed Web of Science ®Google Scholar
• Haas J, Patzold U, Stamm T. Intrahepatische cholestase, eine allergishe reaktion bei azathioprin-therapie [Intrahepatic cholestasis, an allergic reaction in azathioprine therapy?. Dtsch Med Wschr 1978; 103: 1576–1577
   PubMedGoogle Scholar
• Degott C, Rueff B, Kreiss H, Duboust A, Potet F, Benhamou JP. Peliosis hepatis in recipients of renal transplants. Gut 1978; 19: 748–753
   PubMed Web of Science ®Google Scholar
• Zafrani ES, Pinaudeau Y, Dhumeaux D. Druginduced vascular lesions of the liver. Arch Intern Med 1983; 143: 495–502
   PubMedGoogle Scholar
• Katzka DA, Saul SH, Jorkasky D, Sigal H, Reynolds JC, Soloway RD. Azathioprine and hepatic veno-occlusive disease in renal transplant patients. Gastroenterology 1986; 90: 446–454
   PubMed Web of Science ®Google Scholar
• Haboubi NY, Ali HH, Whitwell HL, Ackrill P. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations. Am J Gastroenterol 1988; 83: 256–261
   PubMed Web of Science ®Google Scholar
• Nataf C, Feldmann G, Lebrec D, et al. Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation. Gut 1979; 20: 531–537
   PubMed Web of Science ®Google Scholar
• Weitz H, Gokel JM, Loeschke K, Possinger K, Eder M. Veno-occlusive disease of the liver in patients receiving immunosuppressive therapy. Virchows Arch Pathol Anat 1982; 395: 245–256
   PubMedGoogle Scholar